Skip to Content

Join the 'Avonex Pen' group to help and get support from people like you.

Avonex Pen News

New MS Drug Yields Mixed Results in Study

Posted 7 Oct 2015 by

WEDNESDAY, Oct. 7, 2015 – Multiple sclerosis patients taking a new drug experienced fewer relapse rates but more side effects than patients receiving a standard MS therapy, new research indicates. In a trial comparing two sets of more than 900 patients with relapsing-remitting multiple sclerosis, scientists found that those taking the drug daclizumab HYP had a 45 percent lower relapse rate than ...

Ask a Question

Further Information

Related Condition Support Groups

Multiple Sclerosis

Avonex Pen Patient Information at